Anixa Biosciences (ANIX) Competitors

Anixa Biosciences (NASDAQ:ANIX) and Enzo Biochem (NYSE:ENZ) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, media sentiment, community ranking, institutional ownership, dividends, profitability and earnings.

Which has stronger valuation & earnings, ANIX or ENZ?

Anixa Biosciences has higher earnings, but lower revenue than Enzo Biochem.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anixa Biosciences	$210K	471.97	-$9.81M	-$0.39	-7.90
Enzo Biochem	$31.91M	1.70	-$26.08M	N/A	N/A

Which has more risk & volatility, ANIX or ENZ?

Anixa Biosciences has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500. Comparatively, Enzo Biochem has a beta of 0.73, suggesting that its stock price is 27% less volatile than the S&P 500.

Do analysts prefer ANIX or ENZ?

Anixa Biosciences currently has a consensus target price of $7.00, suggesting a potential upside of 127.27%. Given Anixa Biosciences' stronger consensus rating and higher possible upside, equities analysts clearly believe Anixa Biosciences is more favorable than Enzo Biochem.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anixa Biosciences	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.50
Enzo Biochem	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Does the media refer more to ANIX or ENZ?

In the previous week, Anixa Biosciences had 1 more articles in the media than Enzo Biochem. MarketBeat recorded 3 mentions for Anixa Biosciences and 2 mentions for Enzo Biochem. Anixa Biosciences' average media sentiment score of 0.86 beat Enzo Biochem's score of 0.00 indicating that Anixa Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anixa Biosciences	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Enzo Biochem	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is ANIX or ENZ more profitable?

Anixa Biosciences has a net margin of 0.00% compared to Enzo Biochem's net margin of -81.73%. Enzo Biochem's return on equity of -11.84% beat Anixa Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anixa Biosciences	N/A	-54.79%	-50.37%
Enzo Biochem	-81.73%	-11.84%	-8.31%

Does the MarketBeat Community believe in ANIX or ENZ?

Enzo Biochem received 190 more outperform votes than Anixa Biosciences when rated by MarketBeat users. However, 68.75% of users gave Anixa Biosciences an outperform vote while only 55.35% of users gave Enzo Biochem an outperform vote.

Company	Underperform	Outperform
Anixa Biosciences	Outperform Votes 22 68.75%	Underperform Votes 10 31.25%
Enzo Biochem	Outperform Votes 212 55.35%	Underperform Votes 171 44.65%

Do institutionals & insiders have more ownership in ANIX or ENZ?

29.1% of Anixa Biosciences shares are held by institutional investors. Comparatively, 36.9% of Enzo Biochem shares are held by institutional investors. 22.6% of Anixa Biosciences shares are held by company insiders. Comparatively, 15.5% of Enzo Biochem shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Anixa Biosciences beats Enzo Biochem on 12 of the 17 factors compared between the two stocks.